Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Leukemia
100%
Tumor Antigen
100%
Chronic Lymphocytic Leukemia
100%
Cell Toxicity
100%
Targeted Drug Delivery
100%
Normal B Cells
100%
Cytotoxicity
28%
Targeted Delivery
28%
Cellular Processes
14%
Phosphorylation
14%
Phosphatase
14%
Mouse Model
14%
Cancer Cells
14%
Improved Survival
14%
Malignancy
14%
Mediating Effect
14%
Protein Phosphatase 2A (PP2A)
14%
Cell Surface
14%
Drug Design
14%
Deregulation
14%
SHP-1
14%
Receptor Tyrosine Kinase
14%
Nuclear Translocation
14%
Transgenic Mouse Model
14%
Potential Adverse Effects
14%
FTY720
14%
Acute Lymphoblastic Leukemia
14%
Therapeutic Benefits
14%
Mantle Cell Lymphoma
14%
Leukemia Mice
14%
Traditional Drugs
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Tumor Antigen
100%
Cytotoxicity
100%
Targeted Drug Delivery
100%
Mouse Model
28%
Immunosuppressive Agent
28%
Malignant Neoplasm
14%
Drug Development
14%
Transgenic Mouse
14%
Protein Tyrosine Kinase
14%
Cellular Processes
14%
Acute Lymphoblastic Leukemia
14%
Phosphoprotein Phosphatase 2A
14%
Phosphatase
14%
Fingolimod
14%
Mantle Cell Lymphoma
14%
Medicine and Dentistry
Tumor Antigen
100%
B Cell
100%
B-Cell Chronic Lymphocytic Leukemia
100%
Cytotoxicity
100%
Immunosuppressive Drug
28%
Transgenic Mouse
14%
Cancer Cell
14%
Phosphatase
14%
Cancer
14%
Protein Tyrosine Kinase
14%
Cell Surface
14%
Acute Lymphoblastic Leukemia
14%
Phosphoprotein Phosphatase 2A
14%
Adverse Effect
14%
Fingolimod
14%
Mantle Cell Lymphoma
14%